Subscribe To
Oxford nanopore technologies reports narrowed loss as revenue jumps
Oxford Nanopore Technologies PLC (LSE:ONT) reported a solid increase in full-year revenue driven by growth in its Life Science Research Tools (LSRT) a...
March 21, 2023, 3:27 am
Mainz biomed to present at sidoti virtual investor conference march 22-23
BERKELEY, Calif. and MAINZ, Germany, March 21, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a
March 21, 2023, 3:01 am
Quest diagnostics (dgx) updates its strategic focus, lt growth
Quest Diagnostics (DGX) is building strong platforms to focus on high-growth areas like molecular genom...
March 20, 2023, 11:28 am
Nurix's stock rallies on gilead's option
Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercise...
March 20, 2023, 9:00 am
European dividend gems: symrise ag
Symrise is one of the top players in the highly concentrated aroma molecules, flavours, and fragrances ...
March 16, 2023, 7:12 am
4d molecular therapeutics, inc. (fdmt) reports q4 loss, lags revenue estimates
4D molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of -12% and 74.90%, res...
March 15, 2023, 7:05 pm
Oric pharma: small pfizer deal, cash, and a set of very early stage assets
ORIC has a few early stage cancer targeting molecules. In December, Pfizer made a small $25mn deal with...
March 15, 2023, 12:47 am
What makes applied molecular transport inc. (amti) a new buy stock
Applied molecular Transport Inc. (AMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing ...
March 14, 2023, 1:44 pm
molecular partners ag (moln) q4 2022 earnings call transcript
molecular Partners AG (NASDAQ:MOLN ) Q4 2022 Earnings Conference Call March 10, 2023 8:00 AM ET Company...
March 10, 2023, 1:05 pm
Why is molecular templates (mtem) stock up 36% today?
molecular Templates (NASDAQ: MTEM ) stock is rocketing higher on Friday after the company got approval ...
March 10, 2023, 8:01 am
Co-diagnostics, inc. announces fourth quarter and full year 2022 earnings release date and webcast
SALT LAKE CITY , March 9, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnos...
March 9, 2023, 9:30 am
Betterlife pharma's reports positive study findings for lead candidate betr-001
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) revealed promising findings from a study on its lead candidate BETR-001 (2-bromo-LSD), a non-hallucinoge...
March 9, 2023, 9:27 am
Schrodinger is an ai-powered drug discovery developer to watch
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of ...
March 8, 2023, 7:01 am
Netflix orders new ted danson comedy from creator mike schur
The former Cheers, Becker and The Good Place star will now headline an untitled comedy from Mike Schur (Parks and Recreation, The Good Place) about a ...
March 7, 2023, 1:18 pm
X4 pharmaceuticals to report fourth-quarter and full-year 2022 financial results and host a conference call and webcast on march 21, 2023
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small ...
March 7, 2023, 8:01 am
Enanta pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small
March 7, 2023, 7:00 am
Bridgebio pharma shares soar 55% on positive achondroplasia trial results
BridgeBio Pharma Inc shares have soared more than 55% after the company announced positive data from a Phase 2 clinical trial for its investigational ...
March 6, 2023, 1:21 pm
Garmin (grmn) boosts smartwatch offerings with latest update
Garmin (GRMN) adds AmoleD display feature to its Forerunner 265 and Forerunner 965 GPS running smartwat...
March 6, 2023, 12:02 pm
Annexon reports fourth quarter and year-end 2022 financial results and reiterates anticipated milestones
Initial Clinical Data from Phase 2 Trial of ANX007 in Patients with Geographic Atrophy On-track for Mid-2023 Oral Small ...
March 6, 2023, 11:30 am
Athira pharma to present data supporting therapeutic potential of enhancing hgf/met neurotrophic system at upcoming scientific conferences
BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on deve...
March 6, 2023, 7:00 am